nodes	percent_of_prediction	percent_of_DWPC	metapath
Sitaxentan—CYP2C19—chronic kidney failure	0.496	0.611	CbGaD
Sitaxentan—CYP3A4—chronic kidney failure	0.315	0.389	CbGaD
Sitaxentan—CYP2C9—cardial valve—chronic kidney failure	0.0145	0.326	CbGeAlD
Sitaxentan—CYP2C19—urine—chronic kidney failure	0.00403	0.0907	CbGeAlD
Sitaxentan—CYP2C9—urine—chronic kidney failure	0.00312	0.0703	CbGeAlD
Sitaxentan—EDNRB—urethra—chronic kidney failure	0.00274	0.0618	CbGeAlD
Sitaxentan—EDNRB—cortex of kidney—chronic kidney failure	0.00263	0.0592	CbGeAlD
Sitaxentan—CYP3A4—urine—chronic kidney failure	0.00238	0.0536	CbGeAlD
Sitaxentan—EDNRA—urethra—chronic kidney failure	0.00227	0.0511	CbGeAlD
Sitaxentan—EDNRA—cortex of kidney—chronic kidney failure	0.00217	0.0489	CbGeAlD
Sitaxentan—CYP2C19—blood plasma—chronic kidney failure	0.0021	0.0473	CbGeAlD
Sitaxentan—CYP2C9—blood plasma—chronic kidney failure	0.00163	0.0367	CbGeAlD
Sitaxentan—CYP3A4—blood plasma—chronic kidney failure	0.00124	0.028	CbGeAlD
Sitaxentan—CYP2C19—digestive system—chronic kidney failure	0.000808	0.0182	CbGeAlD
Sitaxentan—CYP2C19—blood—chronic kidney failure	0.00077	0.0173	CbGeAlD
Sitaxentan—CYP2C9—cardiovascular system—chronic kidney failure	0.000755	0.017	CbGeAlD
Sitaxentan—CYP2C9—digestive system—chronic kidney failure	0.000626	0.0141	CbGeAlD
Sitaxentan—CYP2C9—blood—chronic kidney failure	0.000597	0.0134	CbGeAlD
Sitaxentan—CYP3A4—renal system—chronic kidney failure	0.000582	0.0131	CbGeAlD
Sitaxentan—CYP3A4—kidney—chronic kidney failure	0.000563	0.0127	CbGeAlD
Sitaxentan—CYP3A4—digestive system—chronic kidney failure	0.000478	0.0108	CbGeAlD
Sitaxentan—CYP3A4—blood—chronic kidney failure	0.000455	0.0102	CbGeAlD
Sitaxentan—EDNRA—GPCR downstream signaling—CCL5—chronic kidney failure	8.99e-05	0.000622	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling Pathways—PTH—chronic kidney failure	8.9e-05	0.000615	CbGpPWpGaD
Sitaxentan—EDNRB—GPCR downstream signaling—POMC—chronic kidney failure	8.84e-05	0.000612	CbGpPWpGaD
Sitaxentan—EDNRB—Signaling by GPCR—F2—chronic kidney failure	8.82e-05	0.00061	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling Pathways—CYBB—chronic kidney failure	8.67e-05	0.0006	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling by GPCR—AVP—chronic kidney failure	8.65e-05	0.000598	CbGpPWpGaD
Sitaxentan—EDNRA—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—chronic kidney failure	8.63e-05	0.000597	CbGpPWpGaD
Sitaxentan—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A1—chronic kidney failure	8.51e-05	0.000589	CbGpPWpGaD
Sitaxentan—EDNRB—Signaling Pathways—HBEGF—chronic kidney failure	8.23e-05	0.00057	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling by GPCR—EDN1—chronic kidney failure	8.23e-05	0.000569	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling Pathways—FGF23—chronic kidney failure	8.21e-05	0.000568	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling by GPCR—CCL5—chronic kidney failure	8.16e-05	0.000565	CbGpPWpGaD
Sitaxentan—CYP2C19—Metabolism of lipids and lipoproteins—ABCG1—chronic kidney failure	8.13e-05	0.000563	CbGpPWpGaD
Sitaxentan—EDNRA—GPCR downstream signaling—CCR5—chronic kidney failure	8.1e-05	0.00056	CbGpPWpGaD
Sitaxentan—EDNRB—Signaling by GPCR—POMC—chronic kidney failure	8.03e-05	0.000556	CbGpPWpGaD
Sitaxentan—CYP2C19—Metabolism of lipids and lipoproteins—PIP5K1B—chronic kidney failure	7.96e-05	0.000551	CbGpPWpGaD
Sitaxentan—EDNRB—Signaling by GPCR—CCL2—chronic kidney failure	7.86e-05	0.000544	CbGpPWpGaD
Sitaxentan—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—chronic kidney failure	7.82e-05	0.000541	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling Pathways—NPY—chronic kidney failure	7.73e-05	0.000535	CbGpPWpGaD
Sitaxentan—CYP3A4—Biological oxidations—CYP2C19—chronic kidney failure	7.67e-05	0.00053	CbGpPWpGaD
Sitaxentan—CYP2C19—Metabolism of lipids and lipoproteins—LCAT—chronic kidney failure	7.65e-05	0.000529	CbGpPWpGaD
Sitaxentan—CYP3A4—Metapathway biotransformation—CYP2C19—chronic kidney failure	7.56e-05	0.000523	CbGpPWpGaD
Sitaxentan—CYP2C19—Biological oxidations—CYP1A1—chronic kidney failure	7.52e-05	0.00052	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling Pathways—OXT—chronic kidney failure	7.46e-05	0.000516	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling Pathways—CRH—chronic kidney failure	7.46e-05	0.000516	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism of lipids and lipoproteins—ABCG1—chronic kidney failure	7.42e-05	0.000513	CbGpPWpGaD
Sitaxentan—CYP2C19—Metapathway biotransformation—CYP1A1—chronic kidney failure	7.41e-05	0.000513	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling by GPCR—CCR5—chronic kidney failure	7.36e-05	0.000509	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism of lipids and lipoproteins—PIP5K1B—chronic kidney failure	7.26e-05	0.000502	CbGpPWpGaD
Sitaxentan—EDNRB—Signaling Pathways—AVP—chronic kidney failure	7.14e-05	0.000494	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling Pathways—NCF1—chronic kidney failure	7.14e-05	0.000494	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling Pathways—NPS—chronic kidney failure	7.07e-05	0.000489	CbGpPWpGaD
Sitaxentan—CYP3A4—Biological oxidations—PTGS1—chronic kidney failure	7.01e-05	0.000485	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism of lipids and lipoproteins—LCAT—chronic kidney failure	6.97e-05	0.000482	CbGpPWpGaD
Sitaxentan—EDNRA—GPCR downstream signaling—F2—chronic kidney failure	6.95e-05	0.000481	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling Pathways—DRD1—chronic kidney failure	6.93e-05	0.000479	CbGpPWpGaD
Sitaxentan—CYP2C9—Biological oxidations—CYP1A1—chronic kidney failure	6.85e-05	0.000474	CbGpPWpGaD
Sitaxentan—CYP2C19—Metabolism of lipids and lipoproteins—PRKD1—chronic kidney failure	6.82e-05	0.000471	CbGpPWpGaD
Sitaxentan—CYP2C19—Metabolism of lipids and lipoproteins—PRKAG2—chronic kidney failure	6.82e-05	0.000471	CbGpPWpGaD
Sitaxentan—EDNRB—Signaling Pathways—EDN1—chronic kidney failure	6.79e-05	0.00047	CbGpPWpGaD
Sitaxentan—CYP2C9—Metapathway biotransformation—CYP1A1—chronic kidney failure	6.76e-05	0.000468	CbGpPWpGaD
Sitaxentan—EDNRB—Signaling Pathways—CCL5—chronic kidney failure	6.74e-05	0.000466	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling Pathways—CYBA—chronic kidney failure	6.71e-05	0.000464	CbGpPWpGaD
Sitaxentan—EDNRB—Signaling Pathways—LPL—chronic kidney failure	6.59e-05	0.000456	CbGpPWpGaD
Sitaxentan—CYP2C19—Metabolism of lipids and lipoproteins—SREBF2—chronic kidney failure	6.38e-05	0.000441	CbGpPWpGaD
Sitaxentan—CYP3A4—Phase 1 - Functionalization of compounds—POMC—chronic kidney failure	6.34e-05	0.000439	CbGpPWpGaD
Sitaxentan—EDNRA—GPCR downstream signaling—POMC—chronic kidney failure	6.33e-05	0.000438	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling by GPCR—F2—chronic kidney failure	6.31e-05	0.000437	CbGpPWpGaD
Sitaxentan—EDNRB—Signaling Pathways—NGF—chronic kidney failure	6.24e-05	0.000432	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism of lipids and lipoproteins—PRKD1—chronic kidney failure	6.21e-05	0.00043	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism of lipids and lipoproteins—PRKAG2—chronic kidney failure	6.21e-05	0.00043	CbGpPWpGaD
Sitaxentan—CYP2C19—Metabolism of lipids and lipoproteins—ABCC3—chronic kidney failure	6.16e-05	0.000426	CbGpPWpGaD
Sitaxentan—EDNRB—Signaling Pathways—CCR5—chronic kidney failure	6.07e-05	0.00042	CbGpPWpGaD
Sitaxentan—CYP2C19—Metabolism of lipids and lipoproteins—LPIN1—chronic kidney failure	6.03e-05	0.000417	CbGpPWpGaD
Sitaxentan—CYP2C19—Metabolism of lipids and lipoproteins—LRP2—chronic kidney failure	5.91e-05	0.000409	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling Pathways—HBEGF—chronic kidney failure	5.89e-05	0.000408	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism of lipids and lipoproteins—SREBF2—chronic kidney failure	5.82e-05	0.000403	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling by GPCR—POMC—chronic kidney failure	5.75e-05	0.000398	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling by GPCR—CCL2—chronic kidney failure	5.62e-05	0.000389	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism of lipids and lipoproteins—ABCC3—chronic kidney failure	5.62e-05	0.000389	CbGpPWpGaD
Sitaxentan—CYP2C19—Biological oxidations—POMC—chronic kidney failure	5.6e-05	0.000388	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism of lipids and lipoproteins—LPIN1—chronic kidney failure	5.5e-05	0.00038	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism of lipids and lipoproteins—LRP2—chronic kidney failure	5.39e-05	0.000373	CbGpPWpGaD
Sitaxentan—CYP2C19—Metabolism—FABP1—chronic kidney failure	5.28e-05	0.000366	CbGpPWpGaD
Sitaxentan—EDNRB—Signaling Pathways—F2—chronic kidney failure	5.21e-05	0.00036	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling Pathways—AVP—chronic kidney failure	5.11e-05	0.000353	CbGpPWpGaD
Sitaxentan—CYP2C9—Biological oxidations—POMC—chronic kidney failure	5.11e-05	0.000353	CbGpPWpGaD
Sitaxentan—CYP2C19—Metabolism of lipids and lipoproteins—CPT1A—chronic kidney failure	5.02e-05	0.000348	CbGpPWpGaD
Sitaxentan—CYP2C19—Metabolism—AGXT—chronic kidney failure	5.01e-05	0.000347	CbGpPWpGaD
Sitaxentan—CYP2C19—Metabolism—GATM—chronic kidney failure	5.01e-05	0.000347	CbGpPWpGaD
Sitaxentan—EDNRB—Signaling Pathways—IRS1—chronic kidney failure	4.93e-05	0.000341	CbGpPWpGaD
Sitaxentan—CYP2C19—Metabolism of lipids and lipoproteins—LIPC—chronic kidney failure	4.9e-05	0.000339	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling Pathways—EDN1—chronic kidney failure	4.86e-05	0.000336	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling Pathways—CCL5—chronic kidney failure	4.82e-05	0.000334	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism—FABP1—chronic kidney failure	4.82e-05	0.000333	CbGpPWpGaD
Sitaxentan—EDNRB—Signaling Pathways—POMC—chronic kidney failure	4.74e-05	0.000328	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling Pathways—LPL—chronic kidney failure	4.72e-05	0.000326	CbGpPWpGaD
Sitaxentan—EDNRB—Signaling Pathways—CCL2—chronic kidney failure	4.64e-05	0.000321	CbGpPWpGaD
Sitaxentan—CYP2C19—Metabolism—ACAT1—chronic kidney failure	4.58e-05	0.000317	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism of lipids and lipoproteins—CPT1A—chronic kidney failure	4.58e-05	0.000317	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism—AGXT—chronic kidney failure	4.57e-05	0.000316	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism—GATM—chronic kidney failure	4.57e-05	0.000316	CbGpPWpGaD
Sitaxentan—EDNRB—Signaling Pathways—IGF1—chronic kidney failure	4.56e-05	0.000316	CbGpPWpGaD
Sitaxentan—CYP2C19—Metabolism of lipids and lipoproteins—SCARB1—chronic kidney failure	4.52e-05	0.000313	CbGpPWpGaD
Sitaxentan—CYP3A4—Biological oxidations—CYP1A1—chronic kidney failure	4.52e-05	0.000313	CbGpPWpGaD
Sitaxentan—CYP2C19—Metabolism of lipids and lipoproteins—PTGS1—chronic kidney failure	4.48e-05	0.00031	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling Pathways—NGF—chronic kidney failure	4.47e-05	0.000309	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism of lipids and lipoproteins—CYP2C19—chronic kidney failure	4.46e-05	0.000309	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism of lipids and lipoproteins—LIPC—chronic kidney failure	4.46e-05	0.000309	CbGpPWpGaD
Sitaxentan—CYP3A4—Metapathway biotransformation—CYP1A1—chronic kidney failure	4.46e-05	0.000308	CbGpPWpGaD
Sitaxentan—CYP2C19—Metabolism of lipids and lipoproteins—SREBF1—chronic kidney failure	4.39e-05	0.000304	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling Pathways—CCR5—chronic kidney failure	4.34e-05	0.000301	CbGpPWpGaD
Sitaxentan—EDNRB—Signaling Pathways—SERPINE1—chronic kidney failure	4.33e-05	0.0003	CbGpPWpGaD
Sitaxentan—EDNRB—Signaling by GPCR—KRAS—chronic kidney failure	4.29e-05	0.000297	CbGpPWpGaD
Sitaxentan—CYP2C19—Metabolism of lipids and lipoproteins—HMGCR—chronic kidney failure	4.27e-05	0.000296	CbGpPWpGaD
Sitaxentan—CYP2C19—Metabolism—MLXIPL—chronic kidney failure	4.26e-05	0.000295	CbGpPWpGaD
Sitaxentan—CYP2C19—Metabolism of lipids and lipoproteins—FASN—chronic kidney failure	4.18e-05	0.000289	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism—ACAT1—chronic kidney failure	4.18e-05	0.000289	CbGpPWpGaD
Sitaxentan—EDNRB—Signaling Pathways—NOS3—chronic kidney failure	4.14e-05	0.000286	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism of lipids and lipoproteins—SCARB1—chronic kidney failure	4.13e-05	0.000285	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism of lipids and lipoproteins—PTGS1—chronic kidney failure	4.08e-05	0.000282	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism of lipids and lipoproteins—SREBF1—chronic kidney failure	4e-05	0.000277	CbGpPWpGaD
Sitaxentan—CYP2C19—Metabolism—SLC22A2—chronic kidney failure	3.9e-05	0.00027	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism of lipids and lipoproteins—HMGCR—chronic kidney failure	3.9e-05	0.000269	CbGpPWpGaD
Sitaxentan—EDNRB—Signaling Pathways—RELA—chronic kidney failure	3.89e-05	0.000269	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism—MLXIPL—chronic kidney failure	3.88e-05	0.000269	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism of lipids and lipoproteins—FASN—chronic kidney failure	3.81e-05	0.000264	CbGpPWpGaD
Sitaxentan—CYP2C19—Metabolism of lipids and lipoproteins—ABCA1—chronic kidney failure	3.81e-05	0.000263	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling Pathways—F2—chronic kidney failure	3.73e-05	0.000258	CbGpPWpGaD
Sitaxentan—CYP2C19—Metabolism—ABCG1—chronic kidney failure	3.62e-05	0.000251	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism—SLC22A2—chronic kidney failure	3.55e-05	0.000246	CbGpPWpGaD
Sitaxentan—CYP2C19—Metabolism—PIP5K1B—chronic kidney failure	3.54e-05	0.000245	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling Pathways—IRS1—chronic kidney failure	3.53e-05	0.000244	CbGpPWpGaD
Sitaxentan—EDNRB—Signaling by GPCR—IL6—chronic kidney failure	3.49e-05	0.000241	CbGpPWpGaD
Sitaxentan—CYP2C19—Metabolism—ARG2—chronic kidney failure	3.47e-05	0.00024	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism of lipids and lipoproteins—ABCA1—chronic kidney failure	3.47e-05	0.00024	CbGpPWpGaD
Sitaxentan—CYP2C19—Metabolism—LCAT—chronic kidney failure	3.41e-05	0.000236	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling Pathways—POMC—chronic kidney failure	3.4e-05	0.000235	CbGpPWpGaD
Sitaxentan—CYP3A4—Biological oxidations—POMC—chronic kidney failure	3.37e-05	0.000233	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling Pathways—CCL2—chronic kidney failure	3.32e-05	0.00023	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism—ABCG1—chronic kidney failure	3.3e-05	0.000228	CbGpPWpGaD
Sitaxentan—EDNRB—Signaling Pathways—NFKB1—chronic kidney failure	3.28e-05	0.000227	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling Pathways—IGF1—chronic kidney failure	3.27e-05	0.000226	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism—PIP5K1B—chronic kidney failure	3.23e-05	0.000224	CbGpPWpGaD
Sitaxentan—CYP3A4—Metabolism—FABP1—chronic kidney failure	3.18e-05	0.00022	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism—ARG2—chronic kidney failure	3.17e-05	0.000219	CbGpPWpGaD
Sitaxentan—CYP2C19—Metabolism—DDC—chronic kidney failure	3.13e-05	0.000216	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism—LCAT—chronic kidney failure	3.11e-05	0.000215	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling Pathways—SERPINE1—chronic kidney failure	3.1e-05	0.000215	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling by GPCR—KRAS—chronic kidney failure	3.07e-05	0.000212	CbGpPWpGaD
Sitaxentan—CYP2C19—Metabolism—PRKD1—chronic kidney failure	3.04e-05	0.00021	CbGpPWpGaD
Sitaxentan—CYP2C19—Metabolism—CYP2B6—chronic kidney failure	3.04e-05	0.00021	CbGpPWpGaD
Sitaxentan—CYP2C19—Metabolism—PRKAG2—chronic kidney failure	3.04e-05	0.00021	CbGpPWpGaD
Sitaxentan—CYP3A4—Metabolism—AGXT—chronic kidney failure	3.01e-05	0.000208	CbGpPWpGaD
Sitaxentan—CYP3A4—Metabolism—GATM—chronic kidney failure	3.01e-05	0.000208	CbGpPWpGaD
Sitaxentan—CYP2C19—Metabolism of lipids and lipoproteins—LPL—chronic kidney failure	2.99e-05	0.000207	CbGpPWpGaD
Sitaxentan—EDNRB—Signaling Pathways—VEGFA—chronic kidney failure	2.98e-05	0.000206	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling Pathways—NOS3—chronic kidney failure	2.96e-05	0.000205	CbGpPWpGaD
Sitaxentan—CYP2C19—Metabolism of lipids and lipoproteins—CYP1A1—chronic kidney failure	2.89e-05	0.0002	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism—DDC—chronic kidney failure	2.85e-05	0.000197	CbGpPWpGaD
Sitaxentan—CYP2C19—Metabolism—SREBF2—chronic kidney failure	2.84e-05	0.000197	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling Pathways—RELA—chronic kidney failure	2.79e-05	0.000193	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism—PRKD1—chronic kidney failure	2.77e-05	0.000191	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism—PRKAG2—chronic kidney failure	2.77e-05	0.000191	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism—CYP2B6—chronic kidney failure	2.77e-05	0.000191	CbGpPWpGaD
Sitaxentan—CYP3A4—Metabolism—ACAT1—chronic kidney failure	2.76e-05	0.000191	CbGpPWpGaD
Sitaxentan—CYP2C19—Metabolism—ABCC3—chronic kidney failure	2.74e-05	0.00019	CbGpPWpGaD
Sitaxentan—CYP2C19—Metabolism—GCKR—chronic kidney failure	2.74e-05	0.00019	CbGpPWpGaD
Sitaxentan—EDNRB—Signaling Pathways—TGFB1—chronic kidney failure	2.74e-05	0.000189	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism of lipids and lipoproteins—LPL—chronic kidney failure	2.72e-05	0.000188	CbGpPWpGaD
Sitaxentan—CYP2C19—Metabolism—LPIN1—chronic kidney failure	2.69e-05	0.000186	CbGpPWpGaD
Sitaxentan—CYP2C19—Metabolism of lipids and lipoproteins—PPARA—chronic kidney failure	2.64e-05	0.000183	CbGpPWpGaD
Sitaxentan—CYP2C19—Metabolism—LRP2—chronic kidney failure	2.63e-05	0.000182	CbGpPWpGaD
Sitaxentan—CYP2C19—Metabolism—CYP2C18—chronic kidney failure	2.63e-05	0.000182	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism of lipids and lipoproteins—CYP1A1—chronic kidney failure	2.63e-05	0.000182	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism—SREBF2—chronic kidney failure	2.59e-05	0.000179	CbGpPWpGaD
Sitaxentan—CYP3A4—Metabolism—MLXIPL—chronic kidney failure	2.56e-05	0.000177	CbGpPWpGaD
Sitaxentan—EDNRB—Signaling Pathways—KRAS—chronic kidney failure	2.53e-05	0.000175	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism—GCKR—chronic kidney failure	2.5e-05	0.000173	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism—ABCC3—chronic kidney failure	2.5e-05	0.000173	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling by GPCR—IL6—chronic kidney failure	2.5e-05	0.000173	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism—LPIN1—chronic kidney failure	2.45e-05	0.000169	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism of lipids and lipoproteins—PPARA—chronic kidney failure	2.41e-05	0.000166	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism—LRP2—chronic kidney failure	2.4e-05	0.000166	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism—CYP2C18—chronic kidney failure	2.4e-05	0.000166	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling Pathways—NFKB1—chronic kidney failure	2.35e-05	0.000163	CbGpPWpGaD
Sitaxentan—CYP3A4—Metabolism—SLC22A2—chronic kidney failure	2.34e-05	0.000162	CbGpPWpGaD
Sitaxentan—CYP2C19—Metabolism—CPT1A—chronic kidney failure	2.24e-05	0.000155	CbGpPWpGaD
Sitaxentan—CYP2C19—Metabolism—LIPC—chronic kidney failure	2.18e-05	0.000151	CbGpPWpGaD
Sitaxentan—CYP3A4—Metabolism—ABCG1—chronic kidney failure	2.18e-05	0.000151	CbGpPWpGaD
Sitaxentan—CYP2C19—Metabolism of lipids and lipoproteins—POMC—chronic kidney failure	2.15e-05	0.000149	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling Pathways—VEGFA—chronic kidney failure	2.13e-05	0.000148	CbGpPWpGaD
Sitaxentan—CYP3A4—Metabolism—PIP5K1B—chronic kidney failure	2.13e-05	0.000147	CbGpPWpGaD
Sitaxentan—CYP3A4—Metabolism—ARG2—chronic kidney failure	2.09e-05	0.000144	CbGpPWpGaD
Sitaxentan—EDNRB—Signaling Pathways—IL6—chronic kidney failure	2.06e-05	0.000143	CbGpPWpGaD
Sitaxentan—CYP3A4—Metabolism—LCAT—chronic kidney failure	2.05e-05	0.000142	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism—CPT1A—chronic kidney failure	2.04e-05	0.000141	CbGpPWpGaD
Sitaxentan—CYP2C19—Metabolism—SCARB1—chronic kidney failure	2.01e-05	0.000139	CbGpPWpGaD
Sitaxentan—CYP2C19—Metabolism—PTGS1—chronic kidney failure	1.99e-05	0.000138	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism—LIPC—chronic kidney failure	1.99e-05	0.000138	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism—CYP2C19—chronic kidney failure	1.99e-05	0.000138	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism of lipids and lipoproteins—POMC—chronic kidney failure	1.96e-05	0.000136	CbGpPWpGaD
Sitaxentan—CYP2C19—Metabolism of lipids and lipoproteins—ALB—chronic kidney failure	1.96e-05	0.000136	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling Pathways—TGFB1—chronic kidney failure	1.96e-05	0.000135	CbGpPWpGaD
Sitaxentan—CYP2C19—Metabolism—SREBF1—chronic kidney failure	1.96e-05	0.000135	CbGpPWpGaD
Sitaxentan—CYP2C19—Metabolism—HMGCR—chronic kidney failure	1.9e-05	0.000132	CbGpPWpGaD
Sitaxentan—CYP3A4—Metabolism—DDC—chronic kidney failure	1.88e-05	0.00013	CbGpPWpGaD
Sitaxentan—CYP2C19—Metabolism—FASN—chronic kidney failure	1.86e-05	0.000129	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism—SCARB1—chronic kidney failure	1.84e-05	0.000127	CbGpPWpGaD
Sitaxentan—CYP3A4—Metabolism—PRKAG2—chronic kidney failure	1.83e-05	0.000126	CbGpPWpGaD
Sitaxentan—CYP3A4—Metabolism—PRKD1—chronic kidney failure	1.83e-05	0.000126	CbGpPWpGaD
Sitaxentan—CYP3A4—Metabolism—CYP2B6—chronic kidney failure	1.83e-05	0.000126	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism—PTGS1—chronic kidney failure	1.82e-05	0.000126	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling Pathways—KRAS—chronic kidney failure	1.81e-05	0.000125	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism of lipids and lipoproteins—ALB—chronic kidney failure	1.79e-05	0.000124	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism—SREBF1—chronic kidney failure	1.78e-05	0.000123	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism—HMGCR—chronic kidney failure	1.73e-05	0.00012	CbGpPWpGaD
Sitaxentan—CYP2C19—Metabolism—CYP3A4—chronic kidney failure	1.72e-05	0.000119	CbGpPWpGaD
Sitaxentan—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—chronic kidney failure	1.72e-05	0.000119	CbGpPWpGaD
Sitaxentan—CYP3A4—Metabolism—SREBF2—chronic kidney failure	1.71e-05	0.000118	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism—FASN—chronic kidney failure	1.7e-05	0.000117	CbGpPWpGaD
Sitaxentan—CYP2C19—Metabolism—ABCA1—chronic kidney failure	1.7e-05	0.000117	CbGpPWpGaD
Sitaxentan—CYP3A4—Metabolism—GCKR—chronic kidney failure	1.65e-05	0.000114	CbGpPWpGaD
Sitaxentan—CYP3A4—Metabolism—ABCC3—chronic kidney failure	1.65e-05	0.000114	CbGpPWpGaD
Sitaxentan—CYP3A4—Metabolism—LPIN1—chronic kidney failure	1.62e-05	0.000112	CbGpPWpGaD
Sitaxentan—CYP3A4—Metabolism—LRP2—chronic kidney failure	1.58e-05	0.000109	CbGpPWpGaD
Sitaxentan—CYP3A4—Metabolism—CYP2C18—chronic kidney failure	1.58e-05	0.000109	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism—CYP3A4—chronic kidney failure	1.57e-05	0.000109	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—chronic kidney failure	1.56e-05	0.000108	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism—ABCA1—chronic kidney failure	1.55e-05	0.000107	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling Pathways—IL6—chronic kidney failure	1.48e-05	0.000102	CbGpPWpGaD
Sitaxentan—CYP2C19—Metabolism—CAT—chronic kidney failure	1.44e-05	9.93e-05	CbGpPWpGaD
Sitaxentan—CYP2C19—Metabolism—ABCB1—chronic kidney failure	1.4e-05	9.66e-05	CbGpPWpGaD
Sitaxentan—CYP3A4—Metabolism—CPT1A—chronic kidney failure	1.35e-05	9.31e-05	CbGpPWpGaD
Sitaxentan—CYP2C19—Metabolism—LPL—chronic kidney failure	1.33e-05	9.21e-05	CbGpPWpGaD
Sitaxentan—CYP3A4—Metabolism—LIPC—chronic kidney failure	1.31e-05	9.07e-05	CbGpPWpGaD
Sitaxentan—CYP3A4—Metabolism—CYP2C19—chronic kidney failure	1.31e-05	9.07e-05	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism—CAT—chronic kidney failure	1.31e-05	9.06e-05	CbGpPWpGaD
Sitaxentan—CYP2C19—Metabolism—CYP1A1—chronic kidney failure	1.29e-05	8.89e-05	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism—ABCB1—chronic kidney failure	1.27e-05	8.81e-05	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism—LPL—chronic kidney failure	1.21e-05	8.39e-05	CbGpPWpGaD
Sitaxentan—CYP3A4—Metabolism—SCARB1—chronic kidney failure	1.21e-05	8.38e-05	CbGpPWpGaD
Sitaxentan—CYP3A4—Metabolism—PTGS1—chronic kidney failure	1.2e-05	8.3e-05	CbGpPWpGaD
Sitaxentan—CYP2C19—Metabolism—MTHFR—chronic kidney failure	1.2e-05	8.29e-05	CbGpPWpGaD
Sitaxentan—CYP3A4—Metabolism—SREBF1—chronic kidney failure	1.18e-05	8.14e-05	CbGpPWpGaD
Sitaxentan—CYP2C19—Metabolism—PPARA—chronic kidney failure	1.18e-05	8.13e-05	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism—CYP1A1—chronic kidney failure	1.17e-05	8.11e-05	CbGpPWpGaD
Sitaxentan—CYP3A4—Metabolism—HMGCR—chronic kidney failure	1.14e-05	7.92e-05	CbGpPWpGaD
Sitaxentan—CYP3A4—Metabolism—FASN—chronic kidney failure	1.12e-05	7.75e-05	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism—MTHFR—chronic kidney failure	1.09e-05	7.56e-05	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism—PPARA—chronic kidney failure	1.07e-05	7.41e-05	CbGpPWpGaD
Sitaxentan—CYP3A4—Metabolism—ABCA1—chronic kidney failure	1.02e-05	7.05e-05	CbGpPWpGaD
Sitaxentan—CYP2C19—Metabolism—POMC—chronic kidney failure	9.58e-06	6.63e-05	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism—POMC—chronic kidney failure	8.74e-06	6.04e-05	CbGpPWpGaD
Sitaxentan—CYP2C19—Metabolism—ALB—chronic kidney failure	8.74e-06	6.04e-05	CbGpPWpGaD
Sitaxentan—CYP3A4—Metabolism—CAT—chronic kidney failure	8.63e-06	5.97e-05	CbGpPWpGaD
Sitaxentan—CYP3A4—Metabolism—ABCB1—chronic kidney failure	8.4e-06	5.81e-05	CbGpPWpGaD
Sitaxentan—CYP2C19—Metabolism—NOS3—chronic kidney failure	8.36e-06	5.78e-05	CbGpPWpGaD
Sitaxentan—CYP3A4—Metabolism—LPL—chronic kidney failure	8e-06	5.54e-05	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism—ALB—chronic kidney failure	7.97e-06	5.51e-05	CbGpPWpGaD
Sitaxentan—CYP3A4—Metabolism—CYP1A1—chronic kidney failure	7.73e-06	5.35e-05	CbGpPWpGaD
Sitaxentan—CYP2C19—Metabolism—PTGS2—chronic kidney failure	7.64e-06	5.29e-05	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism—NOS3—chronic kidney failure	7.62e-06	5.27e-05	CbGpPWpGaD
Sitaxentan—CYP3A4—Metabolism—MTHFR—chronic kidney failure	7.21e-06	4.98e-05	CbGpPWpGaD
Sitaxentan—CYP3A4—Metabolism—PPARA—chronic kidney failure	7.07e-06	4.89e-05	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism—PTGS2—chronic kidney failure	6.97e-06	4.82e-05	CbGpPWpGaD
Sitaxentan—CYP3A4—Metabolism—POMC—chronic kidney failure	5.76e-06	3.99e-05	CbGpPWpGaD
Sitaxentan—CYP3A4—Metabolism—ALB—chronic kidney failure	5.25e-06	3.63e-05	CbGpPWpGaD
Sitaxentan—CYP3A4—Metabolism—NOS3—chronic kidney failure	5.03e-06	3.48e-05	CbGpPWpGaD
Sitaxentan—CYP3A4—Metabolism—PTGS2—chronic kidney failure	4.6e-06	3.18e-05	CbGpPWpGaD
